Geneva participation highlights Malaysia’s public-private partnership model for early detection and occupational lung health IHH Healthcare Malaysia joined lung health discussions held alongside the 79th World Health Assembly in Geneva, bringing Malaysia’s public-private partnership model to a global platform focused…
Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu Microbot Medical Inc., developer and distributor…
NEJM Publishes Shionogi Phase 3 SCORPIO-PEP Study Showing Ensitrelvir Significantly Reduces COVID-19 Risk After Exposure Shionogi & Co., Ltd. announced that results from its global Phase 3 clinical trial, SCORPIO-PEP, evaluating the investigational oral antiviral ensitrelvir for post-exposure prophylaxis (PEP)…
Cord for Life® Completes Historic Phase 1 Clinical Trial Exploring Cord Blood Stem Cell Therapy for Lower Back Pain Cord for Life®has announced the successful completion of Phase 1 enrollment and dosing in a groundbreaking clinical trial investigating the use…
Dana-Farber to Expand Advanced Cancer Care with Installation of Mevion’s Compact Proton Therapy System The landscape of cancer treatment continues to evolve as healthcare providers increasingly adopt advanced technologies designed to improve patient outcomes while minimizing treatment-related side effects. In…
Health Executives Partner to Create Pioneering Women’s Health AI Initiative The women’s health industry is entering a transformative new era with the launch of the Women’s Health AI Consortium, a groundbreaking initiative created to establish the first clinically rigorous and…
STAAR Surgical Reports Strong First Quarter 2026 Results With Record Sales and Return to Profitability STAAR Surgical Company reported record first quarter 2026 financial results, highlighting significant revenue growth, improved profitability, and continued momentum for its EVO family of Implantable…
HeartBeam Reports Strong First Quarter 2026 Progress as Commercial Expansion and AI-Driven Cardiac Innovation Accelerate HeartBeam, a medical technology company focused on transforming cardiac care through advanced ECG-based solutions, reported financial and operational results for the first quarter ended March…
Turn Therapeutics Publishes First Quarter 2026 Results Alongside Company Updates Turn Therapeutics a clinical-stage biotechnology company focused on developing targeted inflammatory and immunological therapies for dermatologic diseases, has reported its financial results for the first quarter ended March 31, 2026,…
HealthWarehouse.com Reports First Quarter 2026 Financial Results Amid Strategic Shift Toward Technology and AI Partnerships HealthWarehouse.com,a U.S.-based healthcare e-commerce and digital pharmacy company, has reported its financial results for the first quarter ended March 31, 2026. The company also outlined…